Sign up to save your podcasts
Or
Share Can B Corp. Hires Fox Rothschild to Monetize $122 Million Cannabis Patents
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Can B Corp. Hires Fox Rothschild to Monetize $122 Million Cannabis Patents
Can B Corp.'s Nascent Pharma Holdings, Inc. has enlisted the services of Fox Rothschild to protect and monetize its two cannabis patents, which are valued at $122 million and have the potential to exceed $750 million. These patents cover liquid cannabis formulations with high concentrations of CBD, THC, and other components, designed for use in various products. Can B Corp. aims to maximize the value of its cannabis patent portfolios and has reorganized its holding company to strengthen its position in the market.
View all episodes
Can B Corp.'s Nascent Pharma Holdings, Inc. has enlisted the services of Fox Rothschild to protect and monetize its two cannabis patents, which are valued at $122 million and have the potential to exceed $750 million. These patents cover liquid cannabis formulations with high concentrations of CBD, THC, and other components, designed for use in various products. Can B Corp. aims to maximize the value of its cannabis patent portfolios and has reorganized its holding company to strengthen its position in the market.